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Changes in the response to release of a single synaptic vesicle have generally been attributed to
postsynaptic modification of receptor sensitivity, but considerable evidence now demonstrates
that alterations in vesicle filling also contribute to changes in quantal size. Receptors are not satu-
rated at many synapses, and changes in the amount of transmitter per vesicle contribute to the phys-
iological regulation of release. On the other hand, the presynaptic factors that determine quantal size
remain poorly understood. Aside from regulation of the fusion pore, these mechanisms fall into two
general categories: those that affect the accumulation of transmitter inside a vesicle and those that
affect vesicle size. This review will summarize current understanding of the neurotransmitter cycle
and indicate basic, unanswered questions about the presynaptic regulation of quantal size.The analysis of postsynaptic responses at the neuromus-
cular junction originally suggested that a single vesicle
filled with neurotransmitter is the elementary unit (or
‘‘quantum’’) of synaptic transmission (Katz, 1971). Al-
though quantal size has generally been considered invari-
ant, it has become clear that the response to release of
a single vesicle can change as a function of stimulation
and contributes to forms of plasticity such as long-term
potentiation. However, this modulation of quantal size is
postsynaptic, involving changes in receptor sensitivity or
number.
It has been less widely appreciated that the amount of
transmitter released per vesicle can also vary. The high
affinity of many receptors has suggested that they may
be saturated under physiological conditions, in which
case changes in the amount of transmitter per vesicle
would have no impact on synaptic transmission.
However, considerable evidence now shows that even
high-affinity receptors are not saturated at many if not
most synapses. Changes in vesicle filling thus have great
potential to influence synaptic transmission. The aim of
this review is to summarize our current understanding
of the factors that regulate vesicle filling and to identify
open questions about regulation of quantal size by the
neurotransmitter cycle. The first part reviews evidence
that high-affinity receptors are not saturated and ad-
dresses the diverse observations that indicate presyn-
aptic regulation of quantal size under physiological
circumstances. The main part of the review discusses
the mechanisms that influence vesicle filling, from factors
that influence the cytosolic concentration of transmitter,
such as biosynthesis and recycling, to the H+ electro-
chemical gradient that drives transport, the vesicle con-
ductances that regulate the expression of this gradient,
and the neurotransmitter transporters themselves. In
general, changes in quantal size may reflect changes
in the lumenal concentration of transmitter or changes
in vesicle size, and we consider several models to
account for these possibilities.A Single Synaptic Vesicle Does Not Saturate
Postsynaptic Receptors
In many cases, neurotransmitter can activate receptors
at a considerable distance from the release site. Spillover
from ‘‘private’’ synapses or volume transmission by
‘‘social’’ neuromodulators such as monoamines, acetyl-
choline, and neural peptides is particularly susceptible to
regulation by presynaptic changes in quantal size be-
cause the receptors involved are almost by definition not
saturated under physiological conditions. The activation
of G protein-coupled metabotropic receptors by essen-
tially any classical transmitter, including glutamate and
GABA as well as monoamine, falls into this category.
Changes in the amount of transmitter released per vesicle
will influence both the extent and potentially the duration
of signaling by these receptors. However, it has become
increasingly clear that presynaptic changes in quantal
size also influence the activation of ionotropic receptors
immediately postsynaptic to a release site.
The large amount of transmitter in a synaptic vesicle
might be expected to saturate all the ionotropic receptors
at a synapse, reducing if not eliminating the effect of
changes in vesicle filling. Receptor saturation should
reduce the variation in quantal sizemeasured at an individ-
ual synapse. However, the substantial variation in quantal
size observed even at the neuromuscular junction sug-
gests that postsynaptic receptors are not saturated by
the contents of a single synaptic vesicle (Fatt and Katz,
1952; Van der Kloot, 2003). In the central nervous system,
it has beenmore difficult to assess variation in quantal size
because synapses reside at different distances from the
recording electrode, and electrotonic filtering should pro-
duce inherent variation in quantal size, even if the postsyn-
aptic response to a single quantum were identical at all
synapses. In addition, synapses vary in release probability
and the number of postsynaptic receptors (Murthy et al.,
1997; Nusser et al., 1997). To eliminate these sources
of variability, investigators have used hypertonic media
to stimulate directly only one or a small number ofNeuron 55, September 20, 2007 ª2007 Elsevier Inc. 835
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a local dendritic response. Under these conditions, the
fluctuation in quantal size appears just as large as with
electrical stimulation that activates many boutons (Bek-
kers et al., 1990a; Liu and Tsien, 1995; Liu et al., 1999a;
Forti et al., 1997), indicating that the variation is intrinsic
to an individual synapse. The imaging of local calcium
transients in dendrites further supports the large variability
in response at a single synapse (Mainen et al., 1999). The
intrinsic variability in quantal size in turn suggests that
receptors are not always saturated by a single quantum
of glutamate.
More recently, the ability to patch directly onto the pre-
synaptic calyx of Held in the auditory pathway has shown
that increasing the concentration of glutamate in the
pipette can increase quantal size measured postsynapti-
cally, directly excluding receptor saturation at that syn-
apse (Ishikawa et al., 2002). Although it might have been
expected that a quantum of glutamate would not saturate
low-affinity AMPA receptors, synaptically released gluta-
mate also fails to saturate high-affinity NMDA receptors
(Mainen et al., 1999; McAllister and Stevens, 2000), possi-
bly because although high, the peak concentration of syn-
aptic glutamate is very short lived and hence activates
only a fraction of receptors. AMPA and NMDA responses
are highly correlated at a given synapse (McAllister and
Stevens, 2000), indicating a presynaptic source for the
variation. At inhibitory synapses, GABAA receptors also
do not appear to be saturated by a quantum of transmitter
(Frerking andWilson, 1996; Barberis et al., 2004). The drug
zolpidem increases the affinity of GABAA receptors and
does not influence quantal size at inhibitory synapses
onto pyramidal cells in layer 2/3 of the cortex, indicating
receptor saturation, but does increase the response
at many other synapses in hippocampus and cortex
(Hajos et al., 2000). Distinct inhibitory synapses onto the
same neuron may even differ in the extent of saturation.
Changes in the amount of transmitter released per vesicle
thus have great potential to influence the ionotropic re-
sponse at central synapses as well as at the neuromuscu-
lar junction.
Presynaptic Regulation of Quantal Size by Activity
If changes in the amount of transmitter released per
vesicle can influence the postsynaptic response, is this
regulated under physiological conditions? At the neuro-
muscular junction, prolonged high-frequency stimulation
reduces quantal size by approximately 20% (Doherty
et al., 1984; Naves and Van der Kloot, 2001). This decline
and the recovery that ensues do not follow a time course
expected for desensitization and resensitization of acetyl-
choline receptors, suggesting a presynaptic mechanism.
Consistent with this, impairment of release delays the
onset of decline in quantal size, as if there were a pool of
synaptic vesicles filled with more transmitter that release
first but are eventually exhausted. Further, activation of
cAMP-dependent protein kinase (PKA) by hypertonic
media can increase quantal size presynaptically by up to836 Neuron 55, September 20, 2007 ª2007 Elsevier Inc.4-fold at the neuromuscular junction (Van der Kloot,
1987a), and the stimulation of either protein kinase C or
nicotinic receptors blocks this increase (Van der Kloot,
1993). The release of the calcitonin gene-related peptide
(CGRP) by motor neurons may influence this regulation
under physiological conditions (Van der Kloot et al.,
1998). Blockade of neural activity for 1 week at the rat
neuromuscular junction substantially increases quantal
size, apparently through a presynaptic mechanism (Wang
et al., 2005). The lack of correlation with activity in muscle
further suggests that this mechanism does not involve
retrograde signaling from the postsynaptic cell.
Growing evidence indicates the presynaptic regulation of
quantal size under physiological conditions. In Drosophila,
quantal size correlates with the rate of foraging. Immedi-
ately after shift from a plate with food to one without, the
flies begin to crawl faster, and those that belong to the fast-
est subgroup show an increase in quantal size and evoked
release that begins 35 min after the shift and appears to
have a presynaptic origin (Steinert et al., 2006). In synapto-
somal preparations from the rat brain, depolarization
increases the vesicular stores of glutamate (Bole et al.,
2002), and stimulation of chromaffin cells increases quantal
size (Pothos et al., 2002). Further, suppression of activity
acts presynaptically to reduce the amplitude ofminiature in-
hibitory events in both developing andmature hippocampal
neurons, perhaps as part of a homeostatic mechanism to
regulate brain excitability (Hartman et al., 2006).
The Neurotransmitter Cycle
The amount of transmitter released per vesicle can be reg-
ulated either before or after fusion. Regulation after vesicle
fusion involves closure of the fusion pore before the full
release of vesicle contents. Although demonstrated quite
convincingly for large dense-core vesicles by a variety of
methods, this ‘‘kiss-and-run’’ mechanism remains contro-
versial for synaptic vesicles and has been reviewed else-
where (Fernandez-Peruchena et al., 2005; Harata et al.,
2006). Interestingly, the extremely rapid release of trans-
mitter through a flickering fusion pore would place ex-
traordinary demands on vesicle refilling (Staal et al.,
2004). In this review, we focus on the regulation of quantal
size before fusion with the plasmamembrane, due directly
to changes in vesicle filling.
The vesicular storage of transmitter poses several prob-
lems inherent in the mechanism of exocytotic release.
First, the activation of postsynaptic receptors generally
depends on the release of large amounts of lumenal trans-
mitter, but the high rates of firing by many neurons would
then deplete the terminal of vesicular stores. To solve this
problem, most transmitters undergo recycling, either di-
rectly back into the nerve terminal or indirectly into glia.
Second, large amounts of lumenal transmitter will require
significant time for refilling, particularly if the transport
mechanism is slow, and this may also limit release. High
rates of transport and a high cytoplasmic concentration
of transmitter will tend to circumvent this problem, and
most vesicular transport activities (for acetylcholine,
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transmitter, consistent with high cytoplasmic concentra-
tions. However, transmitters with intrinsic toxicity, such
as dopamine, may require low cytoplasmic concentra-
tions. In this case, the transport mechanism needs to gen-
erate a steep gradient of transmitter from cytoplasm to
vesicle lumen, and the limited supply of cytosolic sub-
strate will further slow the rate of filling. Along with trans-
port mechanism, transmitter recycling and the cytosolic
concentration of transmitter thus have very important
roles in vesicle filling. The concentration of transmitter in-
side synaptic vesicles depends on the concentration of
substrate available in the cytoplasm, the transport mech-
anism, and nonspecific leakage across the vesicle mem-
brane. We will thus first address factors that regulate the
cytosolic concentration of transmitter, starting with those
involved in recycling.
Plasma Membrane Transporters
After exocytotic release, most classical transmitters are
cleared from the synapse by transport across the plasma
membrane (Figure 1). In the case of essentially all trans-
mitters other than glutamate, reuptake occurs back into
the nerve terminal and is mediated by a family of trans-
porters dependent on cotransport of both Na+ and Cl
(Table 1). The subject of considerable interest for their
role in controlling synaptic transmitter, extrasynaptic spill-
over, and the response to antidepressants and addictive
psychostimulants (Mortensen and Amara, 2003; Blakely
et al., 2005), these transporters also have a crucial role
in transmitter recycling. Loss of the dopamine transporter
in knockout mice increases extracellular dopamine in the
striatum by 5-fold, but the animals also show a 95%
reduction in whole-brain dopamine (Giros et al., 1996;
Jones et al., 1998). Because the vast majority of dopamine
resides in vesicular stores, the analysis shows that de
novo synthesis via tyrosine hydroxylase cannot keep up
with transmitter release. Indeed, striatal slices from wild-
type mice will continue to release dopamine in response
to stimulation for several hours, but slices from dopamine
transporter knockouts fail to release after only a few stim-
uli. The vesicular stores of dopamine thus rely heavily on
reuptake through the dopamine transporter, at least in
the striatum, which contains a high density of dopaminer-
gic terminals.
Recent work on the neuronal glycine transporter GlyT2
further supports a role for plasma membrane reuptake in
transmitter recycling (Table 1). The two related glycine
transporters GlyT1 and GlyT2 differ in the stoichiometry
of coupling to Na+, with GlyT2 predicted to generate par-
ticularly steep concentration gradients (Roux and Suppli-
sson, 2000). GlyT2 is also expressed by neurons, and
GlyT1 by glia (Zafra et al., 1995). The knockout of GlyT1
produces a phenotype of excessive inhibition that involves
respiratory muscles and causes neonatal mortality, sug-
gesting that this transporter has a primary role in glycine
clearance from the synapse (Gomeza et al., 2003a) (Table
1). In contrast, inactivation of GlyT2 produces a startlephenotype similar to that caused by mutations in glycine
receptors (Gomeza et al., 2003b). Indeed, the loss of
GlyT2 reduces quantal size at inhibitory glycinergic synap-
ses, indicating an important role for this transporter in
glycine recycling.
In the case of ACh, hydrolysis by acetylcholinesterase
terminates signaling, and the product choline is then re-
cycled into the nerve terminal. The choline transporter
does not belong to the same family of proteins as the do-
pamine and glycine transporters (Okuda et al., 2000), but
does depend on Na+ and appears to have an equally
important role in recycling transmitter (Table 1). Inactivation
of the choline transporter results in death within 1 hr after
birth, due to respiratory failure (Ferguson et al., 2004).
Interestingly, the choline transporter as well as the glycine
transporters undergo activity-dependent trafficking at
the nerve terminal (Aragon and Lopez-Corcuera, 2003).
The choline transporter in particular resides on a subset
of synaptic vesicles and thus undergoes exocytosis at
precisely the time when choline uptake is needed (Fergu-
son et al., 2003). Because many plasma membrane trans-
porters serve to recycle transmitter, it is surprising that
more do not exhibit a similar form of regulation. A number
show regulated cell-surface trafficking, but few reside on
synaptic vesicles (Blakely et al., 2005). Perhaps constitutive
cell-surface expression has a distinctive role in clearance,
or constitutive uptake of choline is detrimental.
Glutamine-Glutamate Cycle
The mechanism by which glutamate recycles remains
less clear. After synaptic release, glutamate is taken up
Figure 1. The Neurotransmitter Cycle
Most classical transmitters other than glutamate are recaptured by
Na+-/Cl-dependent plasmamembrane neurotransmitter transporters
(PNTs) located at the nerve terminal. However, glutamate is taken up
by excitatory amino acid transporters (EAAT1, -2) expressed on astro-
cytes, converted to glutamine (gln) by the glial enzyme gln synthase,
and transferred back to neurons by the sequential action of glial sys-
tem N transporters SN1 and -2, and neuronal system A (SA) trans-
porters before conversion back to glutamate by glutaminase and
packaging into synaptic vesicles by the vesicular glutamate trans-
porters (VGLUTs). EAAT3 is expressed postsynaptically, by neurons.Neuron 55, September 20, 2007 ª2007 Elsevier Inc. 837
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Neurotransmitter Transporters
NET, norepinephrine (NE) transporter; DAT, dopamine (DA) transporter; GAT, GABA transporter; GlyT, glycine (gly) transporter;
EAAT, excitatory amino acid transporter; CHT, choline transporter.
1(Gu et al., 1996), 2(Xu et al., 2000), 3(Sonders et al., 1997), 4(Giros et al., 1996), 5(Jones et al., 1998), 6(Rudnick and Nelson, 1978),
7(Quick, 2003), 8(Bengel et al., 1998), 9(Lu and Hilgemann, 1999), 10(Jensen et al., 2003), 11(Roux and Supplisson, 2000), 12(Gomeza
et al., 2003a), 13(Gomeza et al., 2003b), 14(Owe et al., 2006), 15(Tong and Jahr, 1994; Huang et al., 2004b; Glowatzki et al., 2006),
16(Wadiche et al., 1995), 17(Levy et al., 1998), 18(Rothstein et al., 1996; Tanaka et al., 1997), 19(Zerangue and Kavanaugh, 1995),
20(Otis et al., 1997; Brasnjo and Otis, 2001; Huang et al., 2004b), 21(Aoyama et al., 2006), 22(Fairman et al., 1995), 23(Huang
et al., 2004a; Takayasu et al., 2005), 24(Eliasof and Jahr, 1996; Arriza et al., 1997), 25(Ferguson et al., 2004).primarily by the Na+-dependent excitatory amino acid
transporters EAAT1 and -2 (Rothstein et al., 1996; Tanaka
et al., 1997; Huang et al., 2004b; Takayasu et al., 2005)
(Figure 1 and Table 1). EAAT1 and -2 are expressed almost
exclusively by astrocytes (Rothstein et al., 1994; Chaudhry
et al., 1995), precluding direct reuptake of glutamate into
the nerve terminal. Recent work has demonstrated ex-
pression of an alternatively spliced EAAT2 isoform at
nerve terminals in the hippocampus (Chen et al., 2004),
but its physiological role there remains uncertain.
Neurochemical studies have shown that most of the
glutamate released as transmitter derives from the precur-
sor glutamine (Hamberger et al., 1979b). Where does this
glutamine come from? After release from neurons, the glu-
tamate taken up by astrocytes is converted into glutamine
by glutamine synthetase (Rothstein and Tabakoff, 1984;
Pow and Robinson, 1994; Pow and Crook, 1996; Winkler838 Neuron 55, September 20, 2007 ª2007 Elsevier Inc.et al., 1999) (Figure 1). Glutamine is then transferred
back to neurons, apparently through the sequential action
of amino acid system N and A transporters.
System N and A transporters were originally described
as Na+-dependent glutamine transport activities in the
liver (Kilberg et al., 1980; Weissbach et al., 1982). Despite
its Na+ dependence, the system N transporter SN1 medi-
ates efflux under physiological conditions (Chaudhry et al.,
1999), and its expression by astrocytes suggests a role in
the efflux of glutamine from glia required for the glutamine-
glutamate cycle (Figure 1). The system A transporters are
closely related to system N but appear to mediate the uni-
directional uptake of glutamine by neurons. Blockade of
system A transporters with the high-affinity substrate
methyl-aminoisobutyric acid has been reported to reduce
quantal size at excitatory synapses formed in culture (Ar-
mano et al., 2002), but the data about localization have
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in dendrites rather than at the nerve terminal (Armano
et al., 2002; Mackenzie et al., 2003). Interfering with gluta-
mine production and transfer can apparently reduce
epileptiform discharges (Bacci et al., 2002; Tani et al.,
2007), but it has been difficult to demonstrate a role for
glutamine uptake in sustained glutamate release (Kam
and Nicoll, 2007).
How can closely related transportersmediate glutamine
efflux from astrocytes but glutamine uptake by neurons?
SN1mediates flux reversal under physiological conditions
because although a Na+-cotransporter, it is also coupled
to H+ exchange, and the resulting electroneutrality elimi-
nates membrane potential as a driving force, leaving
only the concentration gradient of Na+ to produce a shal-
low gradient of glutamine that allows bidirectional gluta-
mine flux around thermodynamic equilibrium (Chaudhry
et al., 2001; Broer et al., 2002). SN2 also couples to H+
exchange (Nakanishi et al., 2001) and appears to have an
overlapping pattern of expression in the mammalian brain
(R.H.E., unpublished data). In contrast to SN1 and -2, the
system A transporters are not coupled to the translocation
of H+ and are therefore electrogenic as well as Na+ depen-
dent (Sugawara et al., 2000a, 2000b; Yao et al., 2000;
Reimer et al., 2000), producing steeper concentration
gradients of neutral amino acids, including glutamine.
The systemA transporters are also expressed by neurons,
but SAT1/SNAT1 appears to be expressed primarily by in-
hibitory neurons (Chaudhry et al., 2002a) and SAT2/
SNAT2 by excitatory neurons (Varoqui et al., 2000) (F.A.
Chaudhry, personal communication). SAT1 was originally
reported to be more selective for glutamine, but both iso-
forms appear to recognize many neutral amino acids
(Mackenzie et al., 2003).
After transfer fromglia, glutamine undergoes conversion
by the neuronal enzyme glutaminase (also known as the
phosphate-activated or kidney glutaminase [PAG]) back
to glutamate prior to exocytotic release (Conti and Minelli,
1994; Laake et al., 1995) (Figure 1). Another isoform origi-
nally identified in the liver may also contribute (Curthoys
andWatford, 1995; Kvamme et al., 2001). Indeed, a recent
knockout of the kidney glutaminase showed remarkably
little impairment of excitatory transmission (Masson
et al., 2006). The animals die shortly after birth, but themet-
abolic function of this glutaminase isoform in nitrogen me-
tabolism or pH balance by the kidney may contribute to
lethality, and baseline excitatory transmission appears
normal. The animals do show a moderate defect in the
response to prolonged high-frequency stimulation and
a complete loss of glutaminase activity in brain extracts,
although the conditions of the enzyme assay may have
precluded detection of the liver isoform. The full role of
glutaminase and indeed the glutamine-glutamate cycle in
excitatory transmission thus remains uncertain.
In contrast, the glutamine-glutamate cycle has a clear
role at particular inhibitory synapses. In the hippocampus,
inhibition of the EAATs reduces quantal size at inhibitory
synapses (Mathews and Diamond, 2003), presumably byblocking uptake of the glutamate ultimately converted to
GABA by glutamic acid decarboxylase. Interestingly, the
effect of EAAT inhibition on inhibitory transmission does
not require exocytosis and vesicle refilling, suggesting
that it operates on a pool of vesicles that are already avail-
able. More recently, it has been shown that inhibition of
glutamine production in astrocytes and transfer to neu-
rons reduces the size of both evoked and miniature inhib-
itory currents in the hippocampus, supporting a role for
the glutamine-glutamate cycle (Liang et al., 2006). In this
case, however, moderate synaptic activity was required
to trigger the reduction. It is also possible that the gluta-
mine-glutamate cycle is particularly important at inhibitory
synapses that lack a presynaptic GABA transporter for
direct recycling.
Why do glutamate and GABA retrieval involve a mecha-
nism as apparently complex as the glutamine-glutamate
cycle? The cycle may have evolved from very similar path-
ways in the liver and kidney, where the components also
undergometabolic regulation. In the liver, periportal hepa-
tocytes express glutaminase and target the ammonia
derived from glutamine to the urea cycle. Perivenous cells
then conjugate any excess ammonia not captured by peri-
portal cells back to glutamine through the action of gluta-
mine synthetase. Periportal cells thus resemble neurons
and perivenous cells astrocytes (Chaudhry et al., 2002b).
In the kidney, metabolic acidosis upregulates both gluta-
minase and SN1, helping to buffer and eliminate the acid
load (Gstraunthaler et al., 2000; Solbu et al., 2005). The
observations in liver and kidney raise the possibility of
parallel mechanisms governing the glutamine-glutamate
cycle in the nervous sytem. The encephalopathy pro-
duced by liver failure may involve a disturbance of this
cycle in the brain.
Biosynthesis and Metabolism
Similar to any enzymatic reaction, transport into vesicles
concentrates lumenal transmitter (the product) to an extent
dependent directly on the cytosolic concentration (sub-
strate). In addition to themechanisms involved in recycling,
biosynthetic enzymes thus influence the cytosolic concen-
tration of transmitter and hence quantal size. In the case of
glutamatergic transmission, kidney and liver glutaminase
may be redundant, accounting for the relatively mild effect
of losing the kidney isoform (Masson et al., 2006). However,
both isoforms appear to undergo regulation by inorganic
phosphate (Curthoys and Watford, 1995), with phosphate
converting the inactive monomeric form of the enzyme to
the active tetramer. Because the Km for phosphate ex-
ceeds cytosolic concentrations of phosphate, changes in
phosphate levels have the potential to influence glutamate
production, but the physiological role of this mechanism in
transmitter release remains unknown.
At inhibitory synapses, the role of the biosynthetic
enzyme glutamic acid decarboxylase (GAD) in regulation
of quantal size has been controversial. GAD upregulates
in response to seizures (Feldblum et al., 1990; Esclapez
andHouser, 1999) and downregulates with deafferentationNeuron 55, September 20, 2007 ª2007 Elsevier Inc. 839
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tion of GAD has been reported to reduce quantal size in
mammals (Murphy et al., 1998; Engel et al., 2001), but to
impair only the probability of release in crustaceans (Golan
and Grossman, 1996). Consistent with the latter result, the
knockout of GAD65 has no clear effect on quantal size, but
rather influences theprobability of release, particularly after
prolonged stimulation (Tian et al., 1999). This effect sug-
gests a role for vesicle filling or at least GAD65 itself in the
regulation of exocytosis. Alternatively, loss of GAD may
result in the fusion of ‘‘empty’’ synaptic vesicles not detect-
able by postsynaptic recording. Enzymes that metabolize
GABA might also be expected to influence quantal size at
inhibitory synapses. Although predicted to have robust
effects on GABA stores (Axmacher et al., 2004), inhibition
of the metabolic enzyme GABA transaminase with the
anticonvulsant vigabatrin has had conflicting effects on in-
hibitory transmission and quantal size (Engel et al., 2001;
Overstreet and Westbrook, 2001).
Tyrosine hydroxylase, the rate-limiting step in catecho-
loamine biosynthesis, has received considerable attention
for its feedback inhibition by L-Dopa and dopamine and
for its regulation by phosphorylation (Zigmond et al.,
1989; Fitzpatrick, 2000). Activating the enzyme increases
dopamine content and release from a variety of cells and
has been used to increase dopamine production by trans-
plants for Parkinson’s disease (Chang et al., 2002). Using
direct, electrochemical measurements of release made
possible by the oxidation of dopamine by a carbon fiber
electrode held at characteristic potentials (Wightmanet al.,
1991; Albillos et al., 1997; Mosharov and Sulzer, 2005),
addition of L-Dopa, the product of tyrosine hydroxylase,
increases quantal size in adrenal chromaffin cells, PC12
cells, and dopamine neurons, whereas tyrosine hydroxy-
lase inhibition mediated by autoreceptors decreases
quantal size (Colliver et al., 2000; Pothos et al., 1996,
1998a, 1998b).
Electrochemistry has also begun to provide the first
direct measurements of cytosolic monoamine concen-
tration. In comparison to vesicular stores, the amount of
cytosolic transmitter is very small and hence may not
correlate well with total cellular contents or quantal
release, particularly if transport into the vesicle is regu-
lated. Although the cytosolic concentration of most classi-
cal transmitters is not known, immunocytochemistry for
glutamate has suggested concentrations in the 1–10 mM
range (Storm-Mathisen and Ottersen, 1990), consistent
with the results obtained with dialyzing glutamate into
the nerve terminal (Ishikawa et al., 2002). However, the
insertion of a carbon fiber electrode into a patch pipette
enables direct access to the cytosol, and either measure-
ment of dopamine levels by cyclic voltammetry or mea-
surement of total catechol by amperometry (Mosharov
et al., 2003). In adrenal chromaffin cells, cytosolic dopa-
mine concentrations range from 5 to 50 mM. Although it
has always been presumed that inhibition of vesicular
monoamine transport would increase cytosolic catechol-
amine levels, direct measurement by intracellular patch840 Neuron 55, September 20, 2007 ª2007 Elsevier Inc.electrochemistry shows no change in cytosolic dopamine
after inhibition of the vesicular monoamine transporter
with reserpine, although total catechol levels do rise pre-
sumably as a result of metabolism (Mosharov et al., 2003).
Indeed, simultaneous inhibition of both the metabolic en-
zyme monoamine oxidase and the vesicular monoamine
transporter increases cytosolic dopamine, as does L-Dopa
alone. Remarkably, the cytosolic concentration of dopa-
mine in dopamine neurons is undetectable (<0.1 mM)
unless augmented by exogenous L-Dopa (E. Mosharov
and D. Sulzer, personal communication). The cytosolic
concentration of at least monoamine transmitters thus
undergoes extremely tight regulation.
Vesicular Neurotransmitter Transport
Because essentially all classical transmitters are synthe-
sized in the cytoplasm or appear there after reuptake, exo-
cytotic release requires transport into secretory vesicles,
and native vesicle preparations exhibit multiple, distinct
transport activities. Transport into the vesicle generally in-
volves the exchange of lumenal H+ for cytoplasmic trans-
mitter and hence depends on a H+ electrochemical gradi-
ent, which is produced by the vacuolar (yeast lysosome)
H+-ATPase. In addition to the cytosolic concentration of
substrate, factors that influence vesicle filling thus include
the activity of the transporter, the magnitude of the driving
force, and the extent of nonspecific leakage across the
vesicle membrane. However, the extremely rapid recy-
cling of synaptic vesicles along with their small size im-
poses a number of other, surprising constraints on the
concomitant recycling of neurotransmitter. First, unlike
plasma membrane channels and transporters, which rely
on large, stable gradients of ions such as Na+, K+, and
Cl, the filling of synaptic vesicles depends on a H+ elec-
trochemical gradient that is both dissipated and regener-
ated with each cycle of exo- and endocytosis. Further,
a lumenal pH of 6 (only 1 mM) corresponds to less than
one freeH+ per vesicle, althoughmany lumenal H+ are pre-
sumably buffered by vesicle proteins, ATP, or transmitter
itself. At the same time, internalizing synaptic vesicles
contain millimolar concentrations of Na+ and Cl, which
presumably leave the vesicle as H+ enter and transmitter
accumulates. Although we still understand little about
how these events are coordinated, themachinery involved
in vesicle filling must operate within their constraints.
H+ Pump
The driving force for neurotransmitter transport into secre-
tory vesicles is provided by the vacuolar H+-ATPase
(Figure 2). Similar in overall structure and function to
the F0/F1-ATPase from mitochondria and bacteria, the
vacuolar H+ pump mediates H+ flux in the opposite direc-
tion under physiological conditions (Inoue et al., 2005).
Rather than using the energy stored in aH+ electrochemical
gradient to produce ATP, the vacuolar pump uses the
energy released by ATP hydrolysis to make a H+ electro-
chemical gradient, and this activity is responsible for
acidification of endosomes and lysosomes as well as
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composed of two domains, a peripheral V1 domain that
catalyzes ATP hydrolysis and an integral membrane V0
domain that translocates H+. Each domain contains multi-
ple subunits, and crystallographic studies are beginning
to characterize the structure (Drory and Nelson, 2006).
Similar to the F-ATPases, the v-ATPase uses a rotary
mechanism, with V1 rotating with respect to V0 during H+
translocation (Nakanishi-Matsui and Futai, 2006). Multiple
observations in yeast also indicate the potential for regu-
lation of vacuolar H+ pump activity. However, the role for
direct regulation of the H+ pump in mammals has not
been explored.
Remarkably, biochemical studies in yeast and genetic
studies in Drosophila have suggested that the vacuolar
H+ pump and in particular the V0 domain has a role in
membrane fusion, independent of its well-established
role in vesicle acidification (Peters et al., 2001; Hiesinger
et al., 2005). A mutation in the V0 a1 subunit inhibits
Figure 2. Vesicular Neurotransmitter Transporters Vary
in Their Dependence on the Chemical and Electrical
Components of the H+ Electrochemical Gradient
The vacuolar-type H+-ATPase (named after the yeast vacuole or lyso-
some, blue) produces the H+ electrochemical gradient that drives the
transport of all classical neurotransmitters into secretory vesicles. In
all cases, the movement of H+ down their electrochemical gradient is
coupled to the transport of transmitter in the opposite direction.
Despite this common H+ exchange mechanism, different vesicular
neurotransmitter transporters (red) rely to differing extents on the
two components of the H+ electrochemical gradient, the chemical gra-
dient DpH and the electrical gradient DJ. Vesicular monoamine and
ACh transport, which involves the exchange of protonated cytosolic
transmitter for two lumenal H+, involves more H+ than charge move-
ment and hence depends more on DpH than DJ. Although the precise
stoichiometry of ionic coupling by vesicular glutamate transport
remains unknown, the transport of anionic glutamate involves the
movement of n H+ and n + 1 charge. The VGLUTs thus depend more
on DJ than DpH. Transport of the zwitterion GABA with no net charge
involves the movement of equal number of H+ and charge, making
VGAT equally dependent on bothDpH andDJ. These differences sug-
gest that vesicles storing monoamines might exhibit a larger DpH than
DJ, and those storing glutamate a larger DJ than DpH. Whether ves-
icles differ in the extent to which they express the two components of
the H+ electrochemical gradient remains unknown, however intracellu-
lar chloride carriers such as the synaptic vesicle ClC-3 promote vesicle
acidification by dissipating the charge developed by the vacuolar H+
pump, secondarily activating the H+ pump to make a larger DpH.
Recent work has also suggested that the intracellular ClCs function
as exchangers of two Cl for one H+ (Picollo and Pusch, 2005; Scheel
et al., 2005).synaptic vesicle exocytosis without affecting acidification.
Although the mechanism for this apparent effect remains
unknown, it is remarkable that another subunit of V0 was
previously suggested to mediate the nonvesicular release
of transmitter (Dunant and Israel, 2000), and the same
subunit has been implicated in the homotypic fusion of
vacuoles in yeast (Peters et al., 2001).
pH Gradient versus Membrane Potential
and the Role of Chloride
In contrast to the paucity of information about regulation of
intrinsic vacuolar H+ pump activity, considerable evidence
indicates an important role for other ions in secondary ac-
tivation of the pump. Isolated synaptic vesicles (and other
acidic intracellular membranes including endosomes and
lysosomes) show minimal acidification with addition of
only ATP. However, the subsequent addition of chloride
results in dramatic acidification, presumably because
the entry of chloride dissipates any developing membrane
potential (DJ) and so enables the H+ pump to generate
a larger DpH (Figure 2). The electrical (DJ) and chemical
(DpH) components of the H+ electrochemical gradient
made by the vacuolar pump can thus be regulated inde-
pendently (Johnson, 1988).
Previous work has identified a family of intracellular
chloride channels responsible for vesicle acidification
(Jentsch et al., 2005) (Figure 2). The analysis of knockout
mice has confirmed the importance of these channels in
the function of the endocytic pathway in kidney and
bone (Piwon et al., 2000; Kornak et al., 2001). However,
the knockout of ClC-3, one of the main isoforms ex-
pressed in brain, shows an early, severe degenerative
phenotype affecting primarily the hippocampus and retina
(Stobrawa et al., 2001). Synaptic vesicles from the ClC-3
knockout show impaired acidification, but the effect on
transmitter release and in particular quantal size was diffi-
cult to assess, presumably because the synapses ex-
pressing ClC-3 degenerate, and the remaining synapses
express another isoform and hence show no impairment.
Interestingly, recent work has suggested that the intra-
cellular ClCs may function as Cl/H+ exchangers rather
than Cl channels (Figure 2). This possibility was originally
suggested by the analysis of a bacterial protein conferring
Cl flux. Reconstitution of the purified protein into artificial
membranes showed a current-voltage relationship that
did not fit the Nernst equation for chloride, but was consis-
tent instead with a transport mechanism involving the ex-
change of one H+ for two Cl (Accardi and Miller, 2004).
Following up on this observation, it was subsequently
found that two intracellular ClCs in mammals, ClC-4 and
ClC-5, similarly exhibit Cl/H+ exchange activity when
expressed at the plasma membrane (Picollo and Pusch,
2005; Scheel et al., 2005). AlthoughClC-3, amajor isoform
on synaptic vesicles, has not itself been shown to mediate
Cl/H+ exchange, the strong evidence for closely related
proteins suggests that ClC-3 behaves similarly. How
then can Cl entry promote vesicle acidification through
a H+ exchange mechanism? The answer lies in theNeuron 55, September 20, 2007 ª2007 Elsevier Inc. 841
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volves the exchange of two Cl for each H+ and hence the
movement of much more charge (3+) than H+ (1). This stoi-
chiometry in turn predicts greater dissipation of DJ than
DpH, still resulting in secondary activation of the H+ pump
and vesicle acidification.On the other hand, the advantages
of a Cl/H+ exchanger over a simple Cl channel remain
unclear.
ClCs may also contribute to the efflux of lumenal chlo-
ride immediately after synaptic vesicle endocytosis. In
contrast to the small number of free lumenal H+ generated
by the H+ pump, endocytosis traps huge amounts of
extracellular Na+ and Cl in the lumen of endosomes and
recycling synaptic vesicles. The intracellular ClCs exhibit
a strong outward rectification when expressed at the
plasma membrane (Friedrich et al., 1999), suggesting
that they mediate chloride efflux from the vesicle much
more rapidly than influx. It is therefore possible that chlo-
ride may exit recycling synaptic vesicles immediately after
endocytosis, then enter more slowly later, as the vesicle
acidifies (Sonawane et al., 2002; Sonawane and Verkman,
2003). Despite the evidence that Cl flux enables the de-
velopment of DpH at the expense of DJ, it is less clear
how a synaptic vesicle or other intracellular compartment
might increase DJ at the expense of DpH.
It is important to note that DJ has been much more dif-
ficult to assess than DpH. Nonetheless, purified chromaf-
fin granules exhibit a substantial DpH even before the
addition of ATP (Holz, 1979), suggesting substantial buff-
ering at low pH, presumably by lumenal protein, and the
addition of ATP increases selectivelyDJ, from substantial
negative to positive potentials. In most other membranes
and particularly synaptic vesicles, the magnitude of DJ
remains unknown. However, recent work has begun to
suggest that synaptic vesicles contain cation channels
that might control membrane potential. The trp channel
TRPM7 appears to reside on synaptic vesicles, and its
downregulation by siRNA reduces quantal size (Krapivin-
sky et al., 2006). A dominant-negative version of the pro-
tein dramatically impairs evoked release, but this may
reflect interactions with the exocytotic machinery rather
than effects on vesicle filling.
Pharmacologic and Physiologic Regulation
of the H+ Electrochemical Gradient
The effect of many psychostimulants indicates the impor-
tance of the H+ electrochemical gradient for neurotrans-
mitter storage and quantal size. In addition to the effects
on plasma membrane transport, amphetamine promotes
the efflux of dopamine from vesicular stores. Amphet-
amine can interact specifically with the vesicular mono-
amine carrier (Peter et al., 1994), but efflux involves at least
in part dissipation of the H+ electrochemical gradient
across the vesicle membrane. Indeed, amphetamine
appears to act like a number of other weak bases, such
as chloroquine, to dissipate the driving force for vesicle fill-
ing with monoamine (Sulzer and Rayport, 1990; Sulzer
et al., 1993). Consistentwith this role at the vesicle, amphet-842 Neuron 55, September 20, 2007 ª2007 Elsevier Inc.amine also reduces quantal size measured by amperome-
try, and increases cytosolic dopamine (Sulzer et al., 1995;
Mosharov et al., 2003).
But is the vesicle H+ electrochemical gradient regulated
under physiological circumstances? In parafollicular cells
of the thyroid gland, stimulation of the plasma membrane
calcium receptor increases vesicle acidification, appar-
ently by activating the vesicle chloride conductance (Bar-
asch et al., 1988; Tamir et al., 1996). Prolonged stimulation
of adrenal chromaffin cells by depolarization or secreta-
gogue also produces increased vesicle acidification,
a greater proportion of larger ‘‘active’’ vesicles that con-
tain a halo around the dense core, and larger quantal
size (Pothos et al., 2002). A similar mechanism may ac-
count for the remarkable, graded increase in quantal
size observed with increasing strength of stimulation, al-
though this has been attributed to regulation of the fusion
pore (Elhamdani et al., 2001). These observations support
the potential to regulate quantal size through changes in
H+ electrochemical gradient as well as cytosolic transmit-
ter concentration. However, it is important to note that the
mechanisms responsible for activity-dependent acidifica-
tion and increased quantal size remain poorly understood.
Transient alkalinization has also been observed im-
mediately before the exocytosis of mast cell granules
(Williams and Webb, 2000). Although this may represent
an entirely distinct phenomenon, such as the opening of
a fusion pore with concomitant alkalinization just prior to
full fusion with the plasma membrane, other work has in-
dicated that alkalinization can actually precede exocytosis
(Han et al., 1999). The mechanisms responsible for vesicle
alkalinization and its relationship to the acidification ob-
served in other systems remain unknown.
Vesicular Neurotransmitter Transporters
The transport of all classical neurotransmitters into secre-
tory vesicles depends on the H+ electrochemical gradient
generated by the vacuolar H+ pump, but the transport of
different transmitters relies to different extents on the
two components of the gradient: DpH and DJ (Figure 2).
Vesicular monoamine and acetylcholine transport depend
primarily onDpH and vesicular glutamate transport on DJ
(Johnson, 1988; Maycox et al., 1988; Carlson et al.,
1989a). Vesicular GABA transport depends more equally
on both DpH and DJ (Kish et al., 1989; Hell et al., 1990).
However, it is important to note that all of the activities
are electrogenic and hence rely at least in part on DJ. Al-
though the distinction between these activities may seem
to depend on subtle differences in energetics, the proteins
responsible belong to three entirely distinct families. We
will now discuss the properties of these proteins, focusing
on their role in synaptic transmission.
Vesicular Monoamine Transport
Vesicular monoamine transport involves the exchange of
cytoplasmic transmitter for two lumenal protons (Johnson
et al., 1981; Knoth et al., 1981) (Table 2). Because mono-
amines are recognized in their protonated state, the
Neuron
ReviewTable 2. Expression, Ionic Coupling, and Synaptic Phenotype Produced by the Loss of Vesicular Neurotransmitter
Transporters
VMAT2, vesicularmonoamine transporter 2; VAChT, vesicular ACh transporter; VGAT, vesicular GABA and glycine (gly) transporter,
also known as VIAAT, vesicular inhibitory amino acid transporter; VGLUT, vesicular glutamate transporter.
1(Knoth et al., 1981; Johnson et al., 1981), 2(Takahashi et al., 1997; Fon et al., 1997; Wang et al., 1997), 3(Nguyen et al., 1998),
4(Prado et al., 2006), 5(Wojcik et al., 2006), 6(Fremeau et al., 2004; Wojcik et al., 2004), 7(Wallen-Mackenzie et al., 2006; Moechars
et al., 2006).reaction involves the movement of only 1+ charge for
every two H+, accounting for the greater dependence on
DpH than DJ. Why is this stoichiometry important? The
ionic coupling is important because it confers the ability
to package huge concentrations of monoamine at equilib-
rium. For a lumenal pH 5.5 and hence DpH 2, coupling
to two H+ will concentrate monoamines 104-fold. An addi-
tional DJ 60 mV (although this is generally not known)
would increase the gradient by an extra 10-fold, for a total
monoamine gradient 105. Indeed, chromaffin granules
contain up to molar concentrations of monoamine, al-
though much of it is insoluble in a morphologically recog-
nizable aggregate, or dense core.
Originally characterized in chromaffin granules, molecu-
lar cloning of the vesicular monoamine transporters
(VMATs) revealed similar properties for both the nonneural
isoform VMAT1 (expressed by chromaffin and other endo-
crine cells) and neuronal VMAT2. Both VMAT1 and -2
recognize dopamine, norepinephrine, and serotonin as
substrates, but VMAT2 has a slightly (2- to 3-fold) higher
apparent affinity and recognizes histamine as well (Peter
et al., 1994; Erickson et al., 1996). Consistent with this,
VMAT2 is expressed by dopaminergic, noradrenergic, se-
rotonergic, and histaminergic neurons in both the central
nervous system and the periphery (Weihe et al., 1994;
Peter et al., 1995).
How does the loss of vesicle transporter influence
monoamine release? In the absence of VMAT2, exocytotic
release is eliminated, and the stores of brain monoamine
are dramatically reduced (Takahashi et al., 1997; Fon
et al., 1997; Wang et al., 1997). The animals can move,
but feed poorly and die within a few days after birth. Con-
sistent with a specific deficiency in vesicular storage,
amphetamines can rescue feeding and prolong survival,
presumably by promoting efflux directly across theplasma membrane and thus circumventing the defect in
exocytotic release. Inhibition of the metabolic enzyme
monoamine oxidase (MAO) also rescues behavior and
improves survival, apparently by simply increasing the
amount of monoamine (Fon et al., 1997). Indeed, MAO
inhibition restores serotonin levels to above wild-type,
but has little effect on dopamine levels, suggesting impor-
tant differences in the regulation of serotonin and dopa-
mine production, possibly due to differences in the feed-
back inhibition of tryptophan and tyrosine hydroxylase
by their products. In addition, the loss of VMAT2 does
not appear to affect the number or recycling of synaptic
vesicles that remain in dopamine neurons (Croft et al.,
2005), suggesting that empty vesicles undergo exocytosis
and that the synaptic vesicle and neurotransmitter cycles
are not directly coupled.
The VMATs also protect against the parkinsonian neu-
rotoxinMPTP by sequestering the activemetabolite inside
secretory vesicles, away from its primary site of action in
mitochondria (Liu et al., 1992b; Takahashi et al., 1997;
Gainetdinov et al., 1998). The submicromolar Km of
VMAT1 and -2 presumably contributes to the sequestra-
tion of toxin and suggests that VMAT2 may also protect
against cytoplasmic toxicity of the normal transmitter do-
pamine itself. Dopamine can indeed injure cells through
a receptor-independent mechanism that involves sponta-
neous oxidation and the production of free radicals. This
mechanism apparently contributes to the toxicity of
amphetamines (Cubells et al., 1994), and VMAT2 has
been shown to protect against the accumulation of mela-
nin, an oxidation product of dopamine, and against other
forms of degeneration (Sulzer et al., 2000; Sang et al.,
2007). On the other hand, low cytosolic levels may also
limit the pool of monoamine available to refill rapidly
cycling synaptic vesicles.Neuron 55, September 20, 2007 ª2007 Elsevier Inc. 843
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amine release evoked by high-frequency stimulation? In
addition to a low Km, which may reduce the available cy-
tosolic monoamine, the VMATs exhibit a relatively slow
maximal turnover rate for saturating concentrations of
substrate. Using radiolabeled versions of the VMAT inhib-
itors tetrabenazine or reserpine to determine the number
of transporters, heterologous expression of VMAT1 and
-2 confers a rate at 29C of 5/s/transporter for serotonin
(Schuldiner et al., 1993; Peter et al., 1994), comparable if
not faster than the rates observed using native chromaffin
granules and brain synaptic vesicles (Scherman, 1986;
Scherman and Boschi, 1988). The rate would presumably
be higher at 37C and the lower apparent affinity substrate
dopamine appears to be transported up to four times
more rapidly than serotonin. Nonetheless, the rates may
be lower in cells such as neurons where substrate is not
saturating. As a result, it may take minutes to refill rapidly
cycling synaptic vesicles, and hence limit quantal size.
Transport activity would be expected to influence quantal
size under these circumstances, but it is very difficult to
isolate effects on quantal size in the context of strong
stimulation. Indeed, the analysis of quantal size by post-
synaptic recording has generally focused on spontaneous
rather than evoked release. Amperometry can detect all
evoked release but the difficulty identifying reliable release
sites complicates its application.
Vesicular Acetylcholine Transport
Originally described at the Torpedo electric organ, the
vesicular acetylcholine transporter (VAChT) resembles
the VMATs in its primary dependence on DpH (Nguyen
et al., 1998). Consistent with this ionic coupling, the
protein eventually identified in C. elegans as required for
ACh release closely resembles the VMATs in sequence
(Alfonso et al., 1993). In contrast to the VMATs, VAChT
exhibits a millimolar Km, suggesting a higher cytoplasmic
concentration of acetylcholine than monoamines that
might be expected to facilitate vesicle filling. Despite its
role at the neuromuscular junction, however, the vesicular
acetylcholine transporter appears even slower than the
VMATs, with a turnover 1/s (Varoqui and Erickson,
1996). This slow rate may contribute to the defects in
ACh release and cognitive impairment observed in mice
with only 45%–65% reduction in VAChT expression
(Prado et al., 2006). In addition, inhibition of VAChT with
the relatively specific compound vesamicol does not
affect vesicle cycling (Parsons et al., 1999), similar to the
observations in VMAT2 knockout mice.
Vesicular GABA Transport
Identified through genetic analysis in C. elegans, the ve-
sicular GABA transporter (VGAT) defines a family of mam-
malian proteins entirely distinct from the VMATs and
VAChT (McIntire et al., 1993b, 1997). Similar to VAChT,
however, VGAT exhibits a very low apparent affinity (Km
5 mM). VGAT (also known as the vesicular inhibitory
amino acid transporter [VIAAT]) is expressed by glyciner-844 Neuron 55, September 20, 2007 ª2007 Elsevier Inc.gic as well as GABAergic neurons, and glycine inhibits
the transport of GABA by VGAT, but the IC50 is so low
(25 mM) that it has been difficult to demonstrate glycine
transport directly in biochemical assays (McIntire et al.,
1997; Chaudhry et al., 1998). Genetic disruption in mice
has provided some of the first evidence that VGAT loads
glycine as well as GABA into synaptic vesicles and is in-
deed required for the release of both transmitters (Wojcik
et al., 2006). Although the mechanism of transport in-
volves H+ exchange, the stoichiometry for H+ remains un-
known. If it involves one H+ (and since GABA is a neutral
zwitterion, 1+ charge), this would produce a gradient of
only 1000-fold for DpH 2 and DJ +60 mV, substan-
tially less than the VMATs. On the other hand, the cytosolic
concentration of GABA presumably exceeds that of dopa-
mine, and even a cytosolic GABA concentration100 mM
would confer high millimolar lumenal concentrations. In
the case of glycine, which is recognized at low apparent
affinity, VGAT may rely on particularly high cytosolic con-
centrations of glycine generated by the neuronal plasma
membrane glycine transporter GLYT2 (Roux and Suppli-
sson, 2000). Interestingly, the GAD65 isoform associates
with synaptic vesicles and may interact specifically with
VGAT—inhibition of GAD appears to reduce VGAT activity
(Jin et al., 2003). For a variety of reasons, VGAT may thus
not need to produce a particularly large gradient of GABA
across the vesicle membrane.
Little is known about howVGATmight contribute to syn-
aptic plasticity. The protein undergoes phosphorylation,
but this does not appear to change its transport activity
(Bedet et al., 2000). On the other hand, VGAT mRNA and
protein downregulate in response to suppression of neural
activity (De Gois et al., 2006), and this has also been ob-
served in association with a reduction in quantal size
(Hartman et al., 2006). Recent work in C. elegans has
also demonstrated a requirement for the protein UNC-46
(related to the lysosome-associated membrane proteins)
in the trafficking of VGAT to the nerve terminal (Schuske
et al., 2007), providing some of the first information about




The transport of glutamate into synaptic vesicles exhibits
several unusual properties. In contrast to the plasma
membrane excitatory amino acid transporters, vesicular
glutamate transport recognizes glutamate but not aspar-
tate (Naito and Ueda, 1985). In addition, it depends pre-
dominantly on DJ rather than DpH and has been sug-
gested to function as an ion channel (dependent only on
DJ) rather than a H+ antiporter (Maycox et al., 1988; Carl-
son et al., 1989a). In large part, the dependence of vesic-
ular glutamate transport on the two components of the H+
electrochemical gradient will depend on which compo-
nent predominates in the membranes under the condi-
tions studied. However, the difference between channel
and transporter mechanism has extremely important
Neuron
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because a channel would concentrate glutamate only
10-fold for DJ60 mV. In contrast, the exchange of cy-
tosolic glutamate for one lumenal H+ would result in the
movement of 2+ charge as well as one H+. For DpH 2
and DJ 60 mV, this coupling would produce a much
larger glutamate gradient 104. Although a cytoplasmic
glutamate concentration10mMwould require a gradient
only 10-fold to produce 100 mM lumenal glutamate,
considerable evidence supports the H+ exchange mecha-
nism. It is true that dissipation ofDpH can haveminimal ef-
fect on vesicular glutamate transport or sometimes even
increase it (Tabb et al., 1992), presumably by increasing
DJ. However, the dissipation of DJ leaves some residual
activity that is abolished by dissipation ofDpH (Tabb et al.,
1992; Bellocchio et al., 2000), strongly supporting the
mechanism of H+ exchange.
Vesicular glutamate transport also exhibits an unusual
biphasic dependence on chloride. Transport is optimal
at 2–10 mM Cl, with some but less activity at 0 and 150
mM (Naito and Ueda, 1985). Presumably, high Cl con-
centrations dissipate the DJ required for transport. How-
ever, the increase in activity produced by low concentra-
tions of chloride is not simply due to the production of
DpH because the activation persists despite clamping
DpH (Wolosker et al., 1996). Indeed, Cl appears to inter-
act at an allosteric site on the transporter that regulates
both forward and reverse flux (Hartinger and Jahn,
1993). Despite these reproducible biochemical observa-
tions, recent work has shown that quantal size does not
vary with intracellular chloride concentration (Price and
Trussell, 2006). Paired whole-cell recordings from pre-
and postsynaptic neurons at the calyx of Held, where
glutamate receptors are not saturated, shows that spon-
taneous events do not vary in size when the presynaptic
terminal is dialyzed with 5–100 mM chloride. How can
this result be reconciled with biochemical observations?
The answer seems to be that measurements of radiotracer
flux examine only the earliest phase of uptake and are
therefore kinetic measurements. In contrast, the analysis
of quantal size almost certainly occurs closer to a thermo-
dynamic equilibrium. It is thus possible that chloride con-
centration affects only the rate of vesicle filling and not the
final gradient of substrate achieved. Indeed, chloride has
been shown to have much less effect on steady-state
measurements of transport, using high concentrations of
glutamate (Wolosker et al., 1996).
Proteins
The vesicular glutamate transporters have also been sug-
gested to perform an entirely distinct cellular function.
They were originally identified as type-I Na+-dependent
inorganic phosphate transporters (Ni et al., 1994), but it
has since become clear that most members of this family
subserve a function other than phosphate transport. Sialin
exports sialic acid from lysosomes (Verheijen et al., 1999;
Morin et al., 2004; Wreden et al., 2005), and the founding
member NaPi-1 has been shown to recognize organic
anions (Busch et al., 1996; Bro¨er et al., 1998). Consistentwith a primary role for type-I phosphate transporters in
the transport of organic anions, the VGLUTs also belong
to this family. It remains less clear whether any of these
proteins actually mediate phosphate transport. Glutamate
transport by the VGLUTs does not depend on Na+, and
high concentrations of inorganic phosphate do not inhibit
glutamate uptake by VGLUT1 (Bellocchio et al., 2000). In-
deed, heterologous expression of the VGLUTs appears to
upregulate endogenous, low-affinity phosphate transport
(which can be Na+-independent) through unknown mech-
anisms (R.H.E., unpublished data), very similar to NaPi-1
(Bro¨er et al., 1998). On the other hand, the recent purifica-
tion and functional reconstitution of VGLUT2 has shown
that this protein can catalyze Na+-dependent phosphate
transport in addition to glutamate/H+ exchange (Juge
et al., 2006). Further, a series of mutations that disrupt
glutamate transport do not affect phosphate uptake, sug-
gesting that the two substrates translocate through differ-
ent mechanisms. Although a role for phosphate transport
by the VGLUTs remains uncertain, it might contribute to
activation of the phosphate-activated glutaminase and
hence glutamate production at the nerve terminal (Belloc-
chio et al., 1998). Because the VGLUTs reside on synaptic
vesicles, this might confer a mechanism to couple gluta-
mate production to exocytotic glutamate release.
Heterologous expression of the VGLUTs confers essen-
tially all of the properties previously reported for glutamate
uptake by brain synaptic vesicles, including specificity
for glutamate and a biphasic dependence on chloride
(Bellocchio et al., 2000; Takamori et al., 2000; Fremeau
et al., 2001; Takamori et al., 2001; Herzog et al., 2001; Fre-
meau et al., 2002; Takamori et al., 2002; Gras et al., 2002;
Varoqui et al., 2002). Interestingly, the related NaPi-1 ex-
hibits a large chloride conductance inhibited by organic
anions (Busch et al., 1996), raising the question whether
other type-I phosphate transporters do as well. VGLUT1
exhibits a chloride conductance, and this is inhibited by
glutamate, but not aspartate (Bellocchio et al., 2000).
The relationship between glutamate transport and chlo-
ride conductance also remains unclear, and might con-
tribute to the unusual chloride dependence of VGLUTs.
The poor understanding of vesicular glutamate transport
derives from the very limited assays currently available,
particularly after heterologous expression.
Distribution and Synaptic Role
The three known VGLUT isoforms show almost mutually
exclusive patterns of expression in the adult brain.
VGLUT1 is expressed by excitatory neurons in the cortex,
hippocampus, and cerebellar cortex (granule cells),
whereas VGLUT2 is expressed by cells in the thalamus
and brainstem (Bellocchio et al., 2000; Takamori et al.,
2000; Fremeau et al., 2001; Takamori et al., 2001; Herzog
et al., 2001; Fremeau et al., 2002; Gras et al., 2002; Varoqui
et al., 2002). The loss of VGLUT1 indeed eliminates release
at mature synapses that express VGLUT1 in adulthood
(Fremeau et al., 2004). During development, however, the
transient, early expression of VGLUT2 in hippocampus
and cerebellum confers residual, VGLUT1-independentNeuron 55, September 20, 2007 ª2007 Elsevier Inc. 845
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terms of baseline characteristics and to originate from
distinct synapses. Nonetheless, VGLUT2 synapses that
remain in the developing hippocampus of VGLUT1 knock-
out mice show more rapid synaptic depression than wild-
type, suggesting either that these synapses recycle their
vesicles more slowly than the VGLUT1 synapses of wild-
type mice or that VGLUT1 and -2 differ in their recycling.
Indeed, more recent work has shown that VGLUT1 but
not VGLUT2 interacts with proteins involved in synaptic
vesicle endocytosis, and these interactions confer differ-
ences in the rate of recycling (Voglmaier et al., 2006). The
VGLUT1 knockout also shows abnormal endocytic struc-
tures (Fremeau et al., 2004), suggesting effects of the
transporter on aspects of the synaptic vesicle cycle. Like
VMAT2 and VAChT, however, inhibition of vesicular gluta-
mate transport with the H+ pump inhibitor bafilomycin
does not affect vesicle recycling (Zhou et al., 2000), and
analysis of the VGLUT1 knockout confirms the release of
empty vesicles (Wojcik et al., 2004). TheVGLUT2knockout
shows a severe impairment of glutamate release at synap-
ses in the brainstem responsible for respiration, and hence
dies shortly after birth (Wallen-Mackenzie et al., 2006;
Moechars et al., 2006).
In contrast to VGLUT1 and -2, VGLUT3 is expressed by
cells not traditionally associated with glutamate, such as
serotonergic neurons in dorsal and medial raphe nuclei,
cholinergic interneurons in the striatum, and a subset of
GABAergic interneurons in cortex and hippocampus
(Gras et al., 2002; Fremeau et al., 2002; Schafer et al.,
2002). VGLUT3 has also been detected outside the ner-
vous system, and unlike VGLUT1 and -2, heterologous ex-
pression has not thus far been found to confer glutamate
release (Takamori et al., 2002), raising questions about
its physiological role. In addition to a potential role as
transmitter, the glutamate stored by VGLUT3might simply
modulate storage and/or release of the other classical
transmitter usually associated with VGLUT3+ neurons
(e.g., serotonin in the raphe, ACh in striatal interneurons,
and GABA in cortical and hippocampal interneurons). Al-
ternatively, the glutamate stored by VGLUT3 might serve
a metabolic role. However, several observations support
a role for VGLUT3 in glutamate release.
VGLUT3 exhibits a subcellular location distinct from
VGLUT1 and -2. In projection neurons such as serotoner-
gic neurons in the raphe nuclei, VGLUT3 appears re-
stricted to axon terminals like VGLUT1 and -2, but local-
izes to the cell body and dendrites as well as axon of
cholinergic interneurons in the striatum, and GABAergic
interneurons in hippocampus and cortex (Fremeau et al.,
2002). VGLUT3 also localizes to the dendrites of pyramidal
neurons in the cortex, where it contributes to dendritic glu-
tamate release, a novel form of retrograde synaptic signal-
ing (Harkany et al., 2004). The trafficking of VGLUT3 thus
appears to confer novel modes of glutamate release not
possible with the other isoforms.
The transient expression of VGLUT3 during develop-
ment has suggested a particular role for this isoform in846 Neuron 55, September 20, 2007 ª2007 Elsevier Inc.plasticity. In the auditory system, neurons in the medial
nucleus of the trapezoid body (MNTB) form synapses
that transiently release GABA onto cells of the lateral su-
perior olive (LSO) early in postnatal development, then
switch to glycine (Gillespie et al., 2005). At the same
time, these synapses undergo tonotopic refinement and
strengthening that contribute to sound localization. During
early development, MNTB neurons also release glutamate
that activates postsynaptic NMDA receptors, suggesting
a role in synaptic plasticity, and this glutamate release
coincides with the transient expression of VGLUT3. How-
ever, it remains to be determined whether this glutamate
release actually contributes to synapse development
and sound localization.
SV2 and Other Vesicular Carriers
Membrane proteins other than the H+ pump, ion channels,
and neurotransmitter transporters may also contribute to
the lumenal contents of synaptic vesicles and hence to
quantal size. In addition to its role as a transmitter, anionic
ATP apparently promotes the costorage of cationic trans-
mitters such as serotonin (Bankston and Guidotti, 1996),
but the transporter responsible for ATP uptake by synaptic
vesicles remains unknown. Conversely, the function of
many identified synaptic vesicle membrane proteins re-
mains poorly understood. In particular, the SV2 family of
polytopic membrane proteins shows strong sequence
similarity to a wide range of carbohydrate transporters,
but its biochemical function has eluded characterization.
Knockout of the SV2A isoform results in seizures and
death within weeks after birth, and physiological analysis
has alternatively suggested roles in calcium regulation or
the readily releasable pool of synaptic vesicles (Crowder
et al., 1999; Janz et al., 1999). Interestingly, recent work
has shown that SV2A is a direct target for themajor clinical
anticonvulsant levetiracetam (Keppra) (Lynch et al., 2004).
Despite their sequence similarity to transporters, how-
ever, the SV2 proteins have not been reported to influence
quantal size.
The Determinants of Vesicle Filling
Considering all of the factors involved in the transport of
neurotransmitter into synaptic vesicles, how is filling actu-
ally determined under physiological conditions? A simple
equilibrium based on the factors described above does
not account for the experimental observations, suggest-
ing that additional forces are operative. We now present
several models for vesicle filling, discuss the evidence
for and against them, and consider their implications. All
of these have the potential to influence both the lumenal
concentration of transmitter and vesicle size, but we will
consider these two outcomes separately.
Equilibrium
At equilibrium, the ionic coupling of vesicular neurotrans-
mitter transporters together with the H+ electrochemical
driving force should dictate the concentration gradient of
transmitter across the vesicle membrane (Figure 3). The
Neuron
ReviewFigure 3. The Relationship between Neurotransmitter
Transport Activity and Vesicle Filling
Depending on the circumstances, increasing the number of vesicular
neurotransmitter transporters (green) is predicted to have different
effects on vesicle filling (blue).
Equilibrium model. If a vesicle containing one transporter (left column)
fills to an equilibrium dictated solely by the H+ electrochemical driving
force and the cytosolic concentration of transmitter, then increasing
the number of transporters (right column) will have no effect on lumenal
transmitter concentration. The minimal effects of reduced VGLUT ex-
pression on quantal size in VGLUT1+/ heterozygous mice as well as
the Drosophila neuromuscular junction (Fremeau et al., 2004; Daniels
et al., 2006) suggest that vesicular glutamate transport exhibits these
properties. On the other hand, if the rate of filling is slow relative to
the cycling of synaptic vesicles, then more transporters will increase
the extent of filling achieved before exocytosis (not shown).
Set point model. Secretory vesicles may also fill to a fixed set point not
related directly to the transport mechanism. According to this model,
increased transporter expression increases filling, but only up to
a set point, which may be substantially less than expected from trans-
porter expression. (At the two extremes, a relatively high set point
might have no effect on the increase in vesicle filling, and a relatively
low set point might prevent any increase.) Although lumenal transmit-
ter may provide feedback to the transport machinery through the acti-
vation of heterotrimeric G proteins (Brunk et al., 2006b), there is little
physiological evidence for an independent set point that limits vesicle
filling.
Nonspecific leak (leaky bathtub)model. If vesicles exhibit a nonspecific
leak (i.e., not mediated by the neurotransmitter transporter), then the
number of transporters will influence filling by offsetting this leak,
even at equilibrium. This mechanism presumably accounts for the ob-
served effects of VMAT and VAChT expression on quantal size (Song
et al., 1997; Pothos et al., 2000) and is consistent with the relatively
high nonspecific permeation of cationic transmitters through the
largely anionic phospholipid bilayer.
Osmotic swellingmodel.Because the cytosolic concentration of trans-
mitter, driving force, and ionic coupling of transport often predict
lumenal concentrations of transmitter that exceed physiological osmo-
larity, vesicle filling may also be limited by the development of an
osmotic gradient. This gradient presumably accounts for the swelling
of chromaffin vesicles after loading with exogenous L-Dopa, and their
shrinkage after inhibition of VMAT, aswell as the uniform concentrationnumber of transporters would influence quantal size only if
therewere insufficient time to reach equilibrium, a situation
that might be expected to occur only if filling were slow rel-
ative to the recycling of synaptic vesicles. Indeed, vesicu-
lar monoamine and ACh transport have low turnover num-
bers that could limit vesicle filling. However, the number of
transporters apparently influences quantal size indepen-
dent of the rate of vesicle recycling, implicating additional
forces.
Transporter Expression and Leak
In chromaffin cells as well as dopamine neurons, overex-
pression of VMAT2 increases quantal size measured by
amperometry (Pothos et al., 2000). Because these cells
are relatively quiescent in culture, the effects of VMAT
overexpression appear independent of activity. Over-
expression of VAChT also increases quantal size at the
developing neuromuscular junction (Song et al., 1997).
Conversely, a 50% reduction in VMAT2 (in mice heterozy-
gous for the null allele) both reduces monoamine release
(Fon et al., 1997; Travis et al., 2000) and influences the
behavioral response to amphetamine as well as the sensi-
tivity toMPTP (Wang et al., 1997; Gainetdinov et al., 1998).
A reduction in VAChT by only 45% has major effects on
cognitive function and appears to involve a reduction in
quantal size (Prado et al., 2006).
If secretory vesicles have sufficient time to fill (which is
presumably the case at least for spontaneously released
vesicles), why then does the level of transporter expres-
sion make a difference? Although not established defini-
tively, most of the data are consistent with the presence
of a nonspecific leak of transmitter across the vesicle
membrane (i.e., not mediated by the vesicular transporter)
(Figure 3). Synaptic vesicles and other intracellular mem-
branes used for heterologous expression all exhibit a sub-
stantial nonspecific accumulation ofmonoamine driven by
a H+ electrochemical gradient, even in the absence of
a functional transporter. It is presumed that the unproto-
nated amine diffuses across the vesicle membrane, then
undergoes protonation inside the vesicle, preventing its
efflux. Conversely, a substantial nonspecific efflux must
also exist, and previous work has shown that the efflux
of monoamine from chromaffin granules induced by dissi-
pation of DpH cannot be blocked by specific inhibitors
such as reserpine (Maron et al., 1983). Synaptic vesicles
also exhibit a substantial nonspecific leak not blocked
by inhibitors (Floor et al., 1995). The expression of more
transport protein presumably serves to offset this efflux
even under physiological conditions. In addition to
of lumenal transmitter despite substantial changes in vesicle size (Pot-
hos et al., 1996; Colliver et al., 2000; Bruns et al., 2000; Gong et al.,
2003). Although vesicles that vary in size but not the concentration of
lumenal transmitter might also result from changes in vesicle biogene-
sis, this mechanism seems unlikely to account for the acute changes in
quantal size that result frommanipulation of cytosolic transmitter or the
inhibition of transport, particularly in the case of nonrecycling vesicles
such as chromaffin granules. Nonetheless, it is important to note that
despite the data supporting it, this model violates current thinking
about the inelasticity of cell membranes.Neuron 55, September 20, 2007 ª2007 Elsevier Inc. 847
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exhibit a significant leak of H+, possibly through the H+
pump itself (Nelson et al., 2002). A H+ leak should reduce
transmitter accumulation simply by dissipating the driving
force for transport, but might also promote nonspecific
leak of monoamine by increasing the amount of unproto-
nated transmitter in the vesicle lumen.
Recent work has suggested that the level of VGLUT
expression also influences quantal size. In biochemical
experiments, the available inhibitors reduce the steady-
state accumulation of glutamate as well as the rate of its
accumulation (Wilson et al., 2005). Overexpression of the
VGLUTs in dissociated hippocampal culture and in autap-
ses (single neurons forming synapses onto themselves)
also appears to increase quantal size by a variety of crite-
ria (Wojcik et al., 2004;Wilson et al., 2005). Conversely, the
loss of VGLUT1 and -2 reduces quantal size in autaptic
culture (Wojcik et al., 2004; Moechars et al., 2006). In ad-
dition, the VGLUTs undergo considerable regulation, both
during development and in response to activity. Neurons
in the cortex, hippocampus, and cerebellar granule cells
that make only VGLUT1 in adulthood transiently express
VGLUT2 during early development (Miyazaki et al., 2003;
Fremeau et al., 2004; Boulland et al., 2004). Originally
identified as genes induced by kainic acid and growth
factor (Ni et al., 1994; Aihara et al., 2000), VGLUT1 and
-2 respond to manipulation of activity in culture. Consis-
tent with a homeostatic role, increased activity downregu-
lates VGLUT1 at both the level of RNA and protein (De
Gois et al., 2006). Surprisingly, increased activity also
upregulates VGLUT2. Circadian rhythm also appears to
regulate the expression of VGLUT1, although at the level
of the protein rather than its mRNA (Yelamanchili et al.,
2006).
On the other hand, several observations suggest that
VGLUT expression may not normally limit quantal size.
First, mice heterozygous for a wild-type VGLUT1 allele
do not differ fromwild-type in hippocampal field potentials
(Fremeau et al., 2004). Any reduction in quantal size
should be reflected in this evoked response, so the lack
of difference from wild-type effectively excludes an alter-
ation in quantal size when VGLUT expression is reduced
by half. Second, a reduction in VGLUT expression in
Drosophila does not reduce quantal size—only the fre-
quency of miniature events drops as the level of VGLUT
falls below 10%–20%wild-type (Daniels et al., 2006), pre-
sumably due to the release of ‘‘empty’’ vesicles. Indeed,
a single VGLUT appears sufficient to fill a vesicle at this
synapse. On the other hand, VGLUT overexpression in
Drosophila apparently increases quantal size (Daniels
et al., 2004). Interestingly, increased VGLUT expression
in Drosophila also produces a homeostatic reduction in
quantal content. Although a similar homeostatic mecha-
nism might account for the unchanged quantal size
observed in heterozygous VGLUT1 knockouts, the hippo-
campal slice preparation does not generally exhibit the
same robust homeostasis as the Drosophila neuro-
muscular junction.848 Neuron 55, September 20, 2007 ª2007 Elsevier Inc.How can the observations in vivo be reconciled with the
biochemical results and studies in culture? In the transport
assay, it is important to note that steady-state measure-
ments may reflect limitations of the assay (such as the
consumption of ATP or proteolysis) rather than a true ther-
modynamic equilibrium, and this is an inherent shortcom-
ing of many radiotracer flux assays. In the autapses made
from VGLUT1 knockouts, the miniscule amounts of resid-
ual transport activity may well account for a reduction in
quantal size, but the results from Drosophila suggest
thatmore physiological changes in transport activity might
not have produced detectable changes. It is more difficult
to understand how VGLUT overexpression increases
quantal size while the loss of VGLUT has no effect until it
is almost eliminated. Perhaps VGLUT expression influ-
ences vesicle size during biogenesis, rather than the
extent of filling. The work in Drosophila indeed shows in-
creased vesicle size with VGLUT overexpression (Daniels
et al., 2004). And if the amount of VGLUT expressed does
not influence vesicle filling, why would this differ from the
situation with monoamines and acetylcholine, where
transporter expression does apparently affect quantal
size (Fon et al., 1997; Pothos et al., 2000; Song et al.,
1997)? The difference may again reflect nonspecific leak-
age across the membrane, with cationic transmitter more
permeant than anionic through a bilayer with a high pro-
portion of acidic phospholipid. In addition, it is important
to point out that even if quantal size assessed from spon-
taneous events is not obviously affected by changes in
VGLUT expression, the transporter may become limiting
with high rates of synaptic activity and vesicle recycling,
when it is not possible to measure quantal size directly.
A reduction in VGLUT expression can indeed impair be-
havior dramatically with only modest effect on synaptic
transmission (Smear et al., 2007).
Nonspecific leakage may also account for the differen-
tial effects of transport inhibitors on vesicular storage. In
the absence of stimulation, an inhibitor would be expected
to deplete the stores of transmitter only if there is a leak—
in this case, maintenance of the stores requires ongoing
transport activity. In contrast, stimulation should be re-
quired to deplete the stores of a transmitter that does
not leak. The permanently charged ACh should exhibit
less nonspecific leak than reversibly protonated mono-
amines. Consistent with minimal if any leak, the VAChT in-
hibitor vesamicol does not deplete vesicular stores in the
absence of stimulation (Cabeza and Collier, 1988). Vesa-
micol appears to have no effect until 15% of the ACh
stores are released. Preformed vesiclesmust therefore re-
tain their contents until released, and the requirement for
functional VAChT applies only to recycling vesicles. In
contrast, the VMAT inhibitor reserpine depletes mono-
amines in nonrecycling chromaffin granules within min-
utes, in the absence of strong stimulation (Kozminski
et al., 1998). Monoamine vesicles must thus exhibit a sub-
stantial leak, accounting for the large effects of VMAT2 ex-
pression on quantal size. It is more difficult to reconcile the
apparent lack of ACh leak in the presence of vesamicol
Neuron
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size (Song et al., 1997).
Set Point
In addition to regulation at the level of transcription, vesic-
ular neurotransmitter transporters have been suggested
to undergo direct regulation at the level of the protein or
its activity. A fragment of the cytoskeletal protein fodrin
has been purified as an inhibitor of vesicular GABA and
glutamate transport, but we still know little about the
mechanism or its physiological role (Ozkan et al., 1997;
Tamura et al., 2001). Heterotrimeric G proteins have also
been shown to inhibit both vesicular monoamine and glu-
tamate transport in a variety of systems.Multiple heterotri-
meric G proteins associate with secretory vesicles, and
activation of the G protein ao2 with nonhydrolyzable forms
of GTP inhibits uptake of monoamine and glutamate by
30%–50%, affecting primarily Vmax rather than Km (Pah-
ner et al., 2003; Ahnert-Hilger et al., 1998; Ho¨ltje et al.,
2000; Winter et al., 2005). The mechanism does not obvi-
ously involve a change in vesicle acidification, suggesting
a direct interaction with the transport protein. In platelet
granules that store serotonin and express VMAT2, aq
serves a similar role, and inhibition appears to depend
on lumenal transmitter: in the absence of serotonin (using
mice that lack platelet tryptophan hydroxylase), activated
aq no longer inhibits transport. Inhibition is restored by the
addition of monoamine, both in the serotonin-deficient
platelets and in heterologous expression systems (Holtje
et al., 2003). Thus, G proteins may serve to relay a signal
about lumenal transmitter back to the transporter and pro-
vide a set point for vesicle filling (Figure 3). The lumenal
sensor remains unknown, and it seems improbable that
an internalized receptor would be activated specifically
by high lumenal concentrations of transmitter. However,
deleting part of the large first lumenal loop in VMAT1
and -2 dramatically reduces if not abolishes the inhibition,
implicating this domain in the mechanism (Brunk et al.,
2006a). Remarkably, Gao2 also appears to alter the chlo-
ride dependence of synaptic vesicle glutamate transport,
eliminating it in ao2 knockout mice and shifting it to lower
concentrations when activated by a nonhydrolyzable form
of GTP, although the mechanism remains unclear (Winter
et al., 2005).
The Relationship between Neurotransmitter
and Synaptic Vesicle Cycles
Recentworkhas further suggested thatVAChTmay interact
directly with the v-SNARE synaptobrevin involved in synap-
tic vesicle fusion. A mutation that replaces a glycine in the
ninth transmembranedomain ofC. elegansVAChTortholog
unc-17witharginineessentially eliminates transport activity,
and the resulting uncoordinated phenotype is rescued by
a mutation in the transmembrane domain of synaptobrevin
that replaces an isoleucine with aspartate (Sandoval et al.,
2006).Thisallele-specificsupressionstronglysuggestsadi-
rect interaction of the two proteins and indicates a connec-
tion between the synaptic vesicle and neurotransmittercycles that has not previously been considered. However,
acidic residues introduced into other vesicle proteins also
give partial rescue, raising the alternative possibility that
the interactionmight only serve tostabilize themutant trans-
port protein. As noted above, the inhibition of fillingdoes not
appear to influence synaptic vesicle exocytosis or recycling
incholinergic, aminergic, orglutamatergicneurons (Parsons
et al., 1999;Croft et al., 2005; Zhou et al., 2000;Wojcik et al.,
2004), but the converse remains unexplored. From exten-
sive work reviewed elsewhere (Liu et al., 1999b; Flecken-
stein and Hanson, 2003), we know that changes in mem-
brane trafficking have the potential to influence transporter
number at both the plasma membrane and on secretory
vesicles, but we are only beginning to understand its phys-
iological regulation.
The Control of Vesicle Volume
In addition to changes in the concentration of lumenal
contents, secretory vesicles can vary in size. This may oc-
cur during vesicle biogenesis, but several of the changes
observed are acute, suggesting the distention of vesicles
already formed. Because biological membranes are gen-
erally not considered elastic, this is very surprising.
Variation in vesicle size was originally appreciated in the
Torpedo electric organ, which contains two biochemically
distinct populations of synaptic vesicles that can be sep-
arated by density gradient fractionation (Zimmermann and
Denston, 1977). The larger vesicles, termed VP1, contain
3- to 5-fold more ACh than the smaller VP2 vesicles, but
VP2 exhibit substantially higher VAChT activity (Gracz
et al., 1988). In contrast to chromaffin granules, which
increase in size with stimulation (Pothos et al., 2002), VP1
vesicles predominate at rest, and the smaller VP2 appear
with stimulation (Giompres et al., 1981). Although vesicle
populations with distinct size have not been resolved at
the neuromuscular junction, the appearance of vesicles
resembling VP2 may account for the reduction in quantal
size observed at the neuromuscular junction after strong
stimulation (Doherty et al., 1984; Naves and Van der Kloot,
2001). Indeed, preformed vesicles of larger quantal size
have been observed at frog, rat, and snake neuromuscular
junctions (reviewed in Prior and Tian, 1995; Van der Kloot,
2003). After stimulation of the electric organ in Torpedo,
VP2 is slowly replaced by VP1. It has been speculated
that VP1 corresponds to the reserve pool of vesicles ob-
served at many synapses, and VP2 to the recycling pool
(Rizzoli and Betz, 2005). In contrast to the apparently inter-
convertible VP1 and -2, however, imaging experiments
with styryl FM dyes suggest that reserve and recycling
pools are functionally if notmorphologically and biochemi-
cally distinct. Remarkably, the membrane of VP2 appears
to be twice the thickness of VP1 (Van der Kloot, 2003),
suggesting that the vesicles may indeed simply swell
with transmitter accumulation. Regardless of whether
VP1 and -2 are biochemically distinct vesicle populations,
or interconvertible due to changes in filling, the observa-
tions suggest general principles that may also pertain at
other synapses.Neuron 55, September 20, 2007 ª2007 Elsevier Inc. 849
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supported the influence of filling on vesicle size. After
supplementation of pheochromocytoma PC12 cells with
L-Dopa, the total amount of dopamine released per large
dense-core vesicle increases, but remarkably, the con-
centration does not change (Colliver et al., 2000; Gong
et al., 2003). (The two modes of electrochemical record-
ing, amperometry and voltammetry, permit this distinction
to be made, as does capacitance, which measures vesi-
cle membrane surface area after exocytosis.) Consistent
with a selective effect on the amount but not the concen-
tration of transmitter released, dense-core vesicle size
increases after addition of L-Dopa, and only the halo sur-
rounding the dense core enlarges, without an effect on the
dense core itself (Colliver et al., 2000). Increasing cyto-
solic transmitter thus has the potential to increase vesicle
size independent of an increase in lumenal concentration,
suggesting that existing vesicles may swell to accommo-
date more contents. Further supporting this hypothesis,
variation in quantal size correlates well with variation in
vesicle volume in the leech, and the average concentra-
tion of transmitter released per vesicle seems not to differ
despite major differences in vesicle size (Bruns et al.,
2000).
How can the lumenal concentration of transmitter be so
precisely controlled? One simple possibility is that the
development of an osmotic gradient will tend to oppose
filling and so impose a relatively uniform constraint on all
vesicles (Figure 3). The H+ electrochemical gradient may
thus serve to produce both a gradient of transmitter and
an osmotic gradient that will eventually limit the lumenal
accumulation of transmitter. The ionic coupling of many
vesicular neurotransmitter transporters, along with the
known or estimated cytosolic concentration of transmit-
ter, are predicted to generate hyperosmolar lumenal con-
tents, which, if they do not precipitate, might be expected
to distend the vesicle, presumably up to some limit set by
the membrane lipids and the H+ electrochemical driving
force. The selective effect of L-Dopa on the amount but
not the concentration of released dopamine and the
correlation of quantal size with vesicle volume assessed
by capacitance (Colliver et al., 2000; Gong et al., 2003)
are both consistent with this hypothesis.
Alternatively, changes in vesicle size may reflect dif-
ferences in biogenesis and hence intrinsic biochemical
differences in vesicle composition. Several Drosophila
mutants show an increase in quantal size at the neuro-
muscular junction that correlates with increased vesicle
volume (Zhang et al., 1999; Karunanithi et al., 2002). Inter-
estingly, one of the mutations affects the lap gene encod-
ing a Drosophila homolog of clathrin adaptor protein
AP180 (Zhang et al., 1998) and another the lipid phospha-
tase synaptojanin involved in clathrin uncoating (Dickman
et al., 2005), strongly suggesting that the increased size
results from a defect in biogenesis. Quantal size and
vesicle volume both show increased variation in the lap
mutant, consistent with a role for the gene product in the
production of homogeneous vesicles.850 Neuron 55, September 20, 2007 ª2007 Elsevier Inc.Under physiological circumstances, chromaffin cells
have been reported to contain two discrete populations
of dense-core vesicles, and the adaptor protein AP-3 ap-
pears to control their production (Grabner et al., 2005;
Grabner et al., 2006). Overexpression of the neuronal
AP-3 isoform reduces quantal size, and the loss of AP-3
increases quantal size, both changes accompanied by
parallel changes in vesicle size. Interestingly, synaptic
vesicles at 1b and 1s synapses of thewild-typeDrosophila
neuromuscular junction also differ substantially in both
quantal size and vesicle volume (Karunanithi et al.,
2002), further supporting a role for the control of vesicle
volume even under physiological circumstances. The in-
crease in quantal size associated with increased activity
in Drosophila appears to reflect an increase in vesicle
volume (Steinert et al., 2006). In this case, the ability to in-
fluence the appearance of larger quantal events through
manipulations previously shown to affect recruitment of
the reserve and recycling synaptic vesicle pools suggests
that these two, distinct pools account for the variation in
quantal size, although it remains unclear whether they
actually differ in vesicle volume.
An elegant study at the calyx of Held has recently pro-
vided a crucial test for the hypothesis that variation in
quantal size reflects variation in vesicle volume. By aver-
aging a large number of events at many synapses, the au-
thors were able to measure simultaneously the capaci-
tance change associated with fusion of a single vesicle
and quantal size detected postsynaptically (Wu et al.,
2007). The results show no correlation between quantal
size and capacitance jump, strongly suggesting variation
in the concentration of lumenal transmitter rather than
vesicle volume. However, it is important to note that ca-
pacitance detects only the surface area of the plasma
membrane and so can detect differences in vesicle sur-
face area only after fusion with the plasma membrane. If
vesicles swell as a result of osmotic stress during trans-
mitter accumulation, their surface area after fusion pre-
sumably returns to its original, undistended state. Vesicle
surface area before fusion cannot be detected by capac-
itancemeasurements at the plasmamembrane, but rather
requires other methods such as electron microscopy.
Vesicle Filling and Synaptic Plasticity
Howmight changes in vesicle filling contribute to synaptic
plasticity? The diversity of mechanisms that influence the
cytosolic concentration of transmitter, the H+ electro-
chemical driving force, and transport into the vesicle sug-
gests many possibilities. In addition, components of the
release machinery and synaptic vesicle membrane pro-
teins of unknown function may influence this process.
However, we still understand little about these basic
mechanisms and do not as yet have the appropriate bio-
physical methods to study them directly. As a result, we
understand very little about how quantal size is actually
controlled under physiological conditions and how it
changes in synaptic plasticity. In the future, progress will
depend on a combination of molecular and physiological
Neuron
Reviewapproaches to explore such basic questions as how ves-
icle filling influences vesicle volume and the relationship
between different synaptic vesicle pools, which was
originally suggested by classical studies in the Torpedo
electric organ.
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